Risk Factors for a Failed Transmetatarsal Amputation in Patients with Diabetes

被引:2
|
作者
Ron, Itay [1 ,2 ]
Kyin, Cynthia [1 ,3 ]
Peskin, Bezalel [1 ,4 ]
Ghrayeb, Nabil [1 ,4 ]
Norman, Doron [1 ,2 ,4 ]
Ben-Kiki, Tal [1 ,4 ]
Shapira, Jacob [1 ,2 ,4 ]
机构
[1] Rambam Med Ctr, Haifa, Israel
[2] Israel Inst Technol, Ruth & Bruce Rappaport Fac Med 1The, Techn, Haifa, Israel
[3] Univ Cent Florida, Coll Med, Orlando, FL USA
[4] Rambam Med Ctr, Orthoped Dept, Haifa, Israel
来源
关键词
INTRAVENOUS ANTIBIOTICS; MANAGEMENT; FAILURE;
D O I
10.2106/JBJS.22.00718
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background:Transmetatarsal amputation (TMA) is a well-recognized limb-salvage procedure, often indicated for the treatment of diabetic foot infections. Currently, there is no widespread agreement in the literature with regard to the factors associated with failure of TMA. This study aimed to define risk factors for the failure of TMA, defined as below-the-knee or above-the-knee amputation, in patients with diabetes.Methods:This retrospective cohort study included 341 patients who underwent primary TMA. Patients who had a revision to a higher level (the failed TMA group) were compared with those who did not have failure of the initial amputation (the successful TMA group).Results:This study showed a higher frequency of renal impairment, defined as a high creatinine level and/or a previous kidney transplant or need for dialysis, in the failed TMA group (p = 0.002 for both). Furthermore, a Charlson Comorbidity Index (CCI) threshold value of 7.5 was identified as the optimal predictive value for failure of TMA (p = 0.002), and patients with a CCI of >7.5 had a median time of 1.13 months until the initial amputation failed.Conclusions:TMA is associated with a high risk of revision. CCI may be used as a preoperative selection criterion, as 71.8% of patients with a CCI of >7.5 had failure of the TMA.
引用
收藏
页码:651 / 658
页数:8
相关论文
共 50 条
  • [1] Risk Factors for Wound Complications Following Transmetatarsal Amputation in Patients With Diabetes
    Kantar, Rami S.
    Alfonso, Allyson R.
    Rifkin, William J.
    Ramly, Elie P.
    Sharma, Sonali
    Diaz-Siso, J. Rodrigo
    Levine, Jamie P.
    Ceradini, Daniel J.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2019, 243 : 509 - 514
  • [2] FACTORS FAVORING SUCCESSFUL TRANSMETATARSAL AMPUTATION IN DIABETES
    ROOT, HF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1948, 239 (13): : 453 - 458
  • [3] EVALUATION OF THE TRANSMETATARSAL AMPUTATION IN PATIENTS WITH DIABETES MELLITUS
    WHEELOCK, FC
    MCKITTRICK, JB
    ROOT, HF
    [J]. SURGERY, 1957, 41 (02) : 184 - 189
  • [4] Risk Factors for Failure of Transmetatarsal Amputation in Diabetic Patients: A Cohort Study
    Younger, Alastair S. E.
    Awwad, Mohammed A.
    Kalla, Timothy P.
    de Vries, Gwyneth
    [J]. FOOT & ANKLE INTERNATIONAL, 2009, 30 (12) : 1177 - 1182
  • [5] TRANSMETATARSAL AMPUTATION FOR INFECTION OR GANGRENE IN PATIENTS WITH DIABETES MELLITUS
    MCKITTRICK, LS
    MCKITTRICK, JB
    RISLEY, TS
    [J]. ANNALS OF SURGERY, 1949, 130 (04) : 826 - 842
  • [6] TRANSMETATARSAL AMPUTATION FOR INFECTION OR GANGRENE IN PATIENTS WITH DIABETES-MELLITUS
    MCKITTRICK, LS
    MCKITTRICK, JB
    RISLEY, TS
    [J]. JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1993, 83 (02): : 62 - 78
  • [7] REHABILITATION FACTORS FOLLOWING TRANSMETATARSAL AMPUTATION
    MUELLER, MJ
    SINACORE, DR
    [J]. PHYSICAL THERAPY, 1994, 74 (11): : 1027 - 1033
  • [8] Evaluation of Risk Factors for Progression of Proximal Limb Loss After Transmetatarsal Amputation
    Sarad, Nakia
    Rumma, Rowza
    Streeter, Stone
    Verzani, Zoe
    DeRubertis, Brian
    [J]. JOURNAL OF VASCULAR SURGERY, 2023, 78 (04) : E116 - E116
  • [9] TRANSMETATARSAL AMPUTATION
    EFFENEY, DJ
    LIM, RC
    SCHECTER, WP
    [J]. ARCHIVES OF SURGERY, 1977, 112 (11) : 1366 - 1370
  • [10] Therapeutic footwear can reduce plantar pressures in patients with diabetes and transmetatarsal amputation
    Mueller, MJ
    Strube, MJ
    Allen, BT
    [J]. DIABETES CARE, 1997, 20 (04) : 637 - 641